Elvitegravir, cobicistat, emtricitabine, and tenofovir and Ledipasvir and sofosbuvir interaction

Elvitegravir, cobicistat, emtricitabine, and tenofovir and Ledipasvir and sofosbuvir: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Ledipasvir and sofosbuvir label · effective 2025-01-10

Major

Consider alternative HCV or antiretroviral therapy to avoid increases in tenofovir exposures.

Drug interactionsby drug classView label on DailyMed
Moderate

Concomitant Drug Class: Drug Name Effect on Concentration ↓ = decrease, ↑ = increase Clinical Comment tenofovir DF = tenofovir disoproxil fumarate Acid Reducing Agents: ↓ ledipasvir Ledipasvir solubility decreases as pH increases.

Drug interactionsnames Elvitegravir, cobicistat, emtricitabine, and tenofovirView label on DailyMed
Moderate

Regimens containing tenofovir DF and an HIV protease inhibitor/ritonavir or cobicistat atazanavir/ritonavir or cobicistat + emtricitabine/tenofovir DF darunavir/ritonavir or cobicistat + emtricitabine/tenofovir DF lopinavir/ritonavir + emtricitabine/tenofovir DF ↑ tenofovir The safety of increased tenofovir concentrations in the setting of ledipasvir and sofosbuvir…

Drug interactionsnames Elvitegravir, cobicistat, emtricitabine, and tenofovirView label on DailyMed
Moderate

If coadministration is necessary, monitor for tenofovir-associated adverse reactions.

Drug interactionsnames Elvitegravir, cobicistat, emtricitabine, and tenofovirView label on DailyMed
Moderate

Refer to Viread or Truvada prescribing information for recommendations on renal monitoring. elvitegravir, cobicistat, emtricitabine, tenofovir DF ↑ tenofovir The safety of increased tenofovir concentrations in the setting of ledipasvir and sofosbuvir and the combination of elvitegravir, cobicistat, emtricitabine, and tenofovir DF has not been established.

Drug interactionsnames Elvitegravir, cobicistat, emtricitabine, and tenofovirView label on DailyMed

From the Elvitegravir, cobicistat, emtricitabine, and tenofovir (Genvoya) label · effective 2025-02-03

No interaction

…GENVOYA Based on drug interaction studies conducted with the components of GENVOYA, no clinically significant drug interactions have been observed or are expected when GENVOYA is combined with the following drugs: famciclovir, famotidine, ledipasvir, methadone, omeprazole, prasugrel (active metabolite), sertraline, sofosbuvir, velpatasvir, and voxilaprevir.

Drug interactionsnames Ledipasvir and sofosbuvirView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.